Philip Mazzara Sells 4,849 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) General Counsel Philip Mazzara sold 4,849 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.80, for a total value of $600,306.20. Following the sale, the general counsel directly owned 138,084 shares in the company, valued at approximately $17,094,799.20. This trade represents a 3.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Astera Labs Stock Performance

Shares of NASDAQ ALAB traded up $3.04 during mid-day trading on Thursday, reaching $132.62. The company had a trading volume of 2,894,530 shares, compared to its average volume of 5,941,660. The firm has a market cap of $22.40 billion, a price-to-earnings ratio of 108.70, a PEG ratio of 2.55 and a beta of 1.50. The business’s 50-day simple moving average is $160.78 and its 200 day simple moving average is $174.12. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The business had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. During the same quarter last year, the business posted $0.37 EPS. The firm’s revenue for the quarter was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ALAB. BNP Paribas Exane initiated coverage on Astera Labs in a report on Thursday, November 20th. They set an “outperform” rating on the stock. Roth Mkm lifted their target price on shares of Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Needham & Company LLC raised their price target on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, Royal Bank Of Canada initiated coverage on shares of Astera Labs in a report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target on the stock. Fourteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $192.89.

Read Our Latest Report on Astera Labs

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ALAB. Assetmark Inc. lifted its position in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the period. Smartleaf Asset Management LLC increased its position in shares of Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the period. Hilltop National Bank raised its stake in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the last quarter. Aventura Private Wealth LLC acquired a new position in Astera Labs in the fourth quarter valued at $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in Astera Labs during the fourth quarter valued at $33,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Read More

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.